Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 5034.88 | 459 / 459 | 100% | 53.61 | 1118 / 1118 |
esophagus | 100% | 5361.53 | 1445 / 1445 | 100% | 58.18 | 183 / 183 |
lung | 100% | 5473.41 | 578 / 578 | 100% | 47.84 | 1155 / 1155 |
ovary | 100% | 5175.26 | 180 / 180 | 100% | 37.57 | 430 / 430 |
thymus | 100% | 5079.78 | 653 / 653 | 100% | 45.58 | 604 / 605 |
uterus | 100% | 5266.36 | 170 / 170 | 100% | 42.58 | 458 / 459 |
prostate | 100% | 4420.92 | 245 / 245 | 99% | 37.45 | 499 / 502 |
bladder | 100% | 4558.38 | 21 / 21 | 99% | 35.76 | 500 / 504 |
brain | 99% | 2572.11 | 2617 / 2642 | 100% | 36.75 | 705 / 705 |
pancreas | 99% | 1734.55 | 325 / 328 | 99% | 34.35 | 176 / 178 |
stomach | 100% | 3107.60 | 359 / 359 | 98% | 32.69 | 280 / 286 |
intestine | 100% | 4283.29 | 966 / 966 | 98% | 31.58 | 515 / 527 |
kidney | 100% | 2894.15 | 89 / 89 | 97% | 31.33 | 871 / 901 |
adrenal gland | 100% | 3749.11 | 258 / 258 | 95% | 23.53 | 218 / 230 |
liver | 100% | 2218.51 | 226 / 226 | 94% | 18.05 | 382 / 406 |
skin | 100% | 4795.42 | 1809 / 1809 | 93% | 32.59 | 441 / 472 |
adipose | 100% | 4903.44 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 5000.27 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 31.38 | 29 / 29 |
muscle | 100% | 4948.07 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 4737.10 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 44.79 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 14.90 | 1 / 1 |
heart | 98% | 3344.93 | 848 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 96% | 5099.16 | 890 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 78% | 16.55 | 62 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1902018 | Biological process | negative regulation of cilium assembly |
GO_1902916 | Biological process | positive regulation of protein polyubiquitination |
GO_0051865 | Biological process | protein autoubiquitination |
GO_0002643 | Biological process | regulation of tolerance induction |
GO_1905524 | Biological process | negative regulation of protein autoubiquitination |
GO_1901799 | Biological process | negative regulation of proteasomal protein catabolic process |
GO_0042130 | Biological process | negative regulation of T cell proliferation |
GO_0050821 | Biological process | protein stabilization |
GO_1902166 | Biological process | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0006513 | Biological process | protein monoubiquitination |
GO_0043518 | Biological process | negative regulation of DNA damage response, signal transduction by p53 class mediator |
GO_0005886 | Cellular component | plasma membrane |
GO_0005813 | Cellular component | centrosome |
GO_0005634 | Cellular component | nucleus |
GO_0005829 | Cellular component | cytosol |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0097371 | Molecular function | MDM2/MDM4 family protein binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0005515 | Molecular function | protein binding |
GO_0043130 | Molecular function | ubiquitin binding |
GO_0031624 | Molecular function | ubiquitin conjugating enzyme binding |
Gene name | MARCHF7 |
Protein name | RING-type E3 ubiquitin transferase (EC 2.3.2.27) E3 ubiquitin-protein ligase MARCHF7 (EC 2.3.2.27) (Axotrophin) (Membrane-associated RING finger protein 7) (Membrane-associated RING-CH protein VII) (MARCH-VII) (RING finger protein 177) (RING-type E3 ubiquitin transferase MARCHF7) |
Synonyms | MARCH7 RNF177 AXOT |
Description | FUNCTION: E3 ubiquitin-protein ligase which may specifically enhance the E2 activity of HIP2. E3 ubiquitin ligases accept ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfer the ubiquitin to targeted substrates . May be involved in T-cell proliferation by regulating LIF secretion (By similarity). May play a role in lysosome homeostasis . Promotes 'Lys-6', 'Lys-11' and 'Lys-63'-linked mixed polyubiquitination on ATG14 leading to the inhibition of autophagy by impairing the interaction between ATG14 and STX7 . Participates in the dopamine-mediated negative regulation of the NLRP3 inflammasome by promoting its uibiquitination and subsequent degradation . . |
Accessions | H7BZU7 ENST00000409175.6 [Q9H992-1] ENST00000259050.8 [Q9H992-1] ENST00000539065.5 ENST00000420397.1 ENST00000409591.5 [Q9H992-2] Q9H992 ENST00000421037.1 F5H6W4 C9J159 |